ID/IQ parent award for pharmacology and toxicology for therapeutics program (pttp)- SRI international
Active Awarded Last action
- Contract number
- HHSN271201600006I
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 15 $17,062,451 obligated
Award facts
- Opportunity
-
- NIHNINDS1601 Solicitation number
- Pharmacology and Toxicology for Therapeutics Program (PTTP) Award Notice · Posted Mar 4, 2016
- Combined order value
-
- $17,062,451 Current, with exercised options
- $23,776,982 Potential, with all options
- Last date to order 92% complete
- IDV ceiling 10% used
- $174,470,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Neurological Disorders and Stroke awarded an indefinite-delivery contract to Sri International with a ceiling of $174,470,000 on September 13, 2016, for the Pharmacology and Toxicology for Therapeutics Program (PTTP). This is a multiple-award IDIQ with a period of performance extending through September 12, 2027.
Work is performed at Sri International's facility in Menlo Park, California, with subordinate activity in North Bethesda, Maryland and West Menlo Park, California. The IDIQ procures preclinical pharmacology and toxicology services supporting drug candidate development, including rodent and non-rodent pharmacokinetic assessments, IND-enabling GLP toxicology studies, dose-range-finding studies, and clinical chemistry evaluations.
Task orders issued under this IDIQ demonstrate sustained customer demand across both NINDS and the National Institute on Drug Abuse. Representative recent orders include a $7,323,160.93 cost-plus-fixed-fee delivery order for continuous rodent and non-rodent pharmacokinetic assessments (awarded March 2022, extending through March 2027); a $1,469,307 order for rodent and non-rodent pharmacokinetic studies (July 2023, completed July 2026); and a $503,901 order for IND-enabling GLP toxicology studies with Charles River Laboratories Montreal ULC providing subcontracted hemolysis and flocculation studies (September 2022, completed September 2024). Earlier orders, including work through May 2018, cover dog pharmacokinetic and toxicity assessments, GLP toxicology suites, and program management and operations support. Pricing across orders reflects both cost-plus-fixed-fee and firm-fixed-price structures.
Task orders
Show all 15
Transactions
| Action | Obligated | Date |
|---|---|---|
| Definitize Change Order | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN271201600006I?
HHSN271201600006I was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on September 13, 2016.
How much is contract HHSN271201600006I worth?
Orders under HHSN271201600006I have obligated $17,062,451. Their combined potential value, with all options, is $23,776,982. HHSN271201600006I's own ceiling is $174,470,000.
How many orders have been placed under contract HHSN271201600006I?
15 orders have been placed under HHSN271201600006I, the latest on July 3, 2023.
Which agency awarded contract HHSN271201600006I?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201600006I, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Who can order from contract HHSN271201600006I?
HHSN271201600006I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN271201600006I part of a contract vehicle?
Yes. HHSN271201600006I is part of Pharmacology and Toxicology for Therapeutics Program (PTTP).
Was contract HHSN271201600006I competed?
The extent of competition for HHSN271201600006I was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV